CSF corticotropin-releasing hormone and somatostatin in major depression: response to antidepressant treatment and relapse
European NeuropsychopharmacologyPublished 1 June 1992
Csaba M. Bánki, Lajos Karmacsi, Garth Bissette, Charles B. Nemeroff
Citations148
SJR quartileQ1
SJR score1.93
SNIP1.34
Generate an AI Snapshot to get a quick, structured summary of this paper.
Study Snapshot
ObjectiveStudy objective
MethodsResearch methodology
PopulationPopulation studied
Sample sizeSample sizes
OutcomesStudy outcomes here
ResultsStudy results comes here
LimitationsResearch study limitations comes here
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
TL;DR
There was a significant post-treatment reduction of the CSF-CRH concentration in the 15 patients who remained depression-free for at least 6 months following treatment, in contrast to the tendency for elevation in those 9 subjects who relapsed within 6 months.
Abstract
Immunoreactive corticotropin-releasing hormone (CRH) and somatostatin (SRIF) were measured in the cerebrospinal fluid (CSF) of 24 female in-patients, suffering from DSM-III-R major depression, both before and after antidepressant treatment. In the total group there were no significant differences between pre- and post-treatment CSF-CRH and SRIF concentrations despite satisfactory clinical improvement in each patient. However, there was a significant post-treatment reduction of the CSF-CRH concentration in the 15 patients who remained depression-free for at least 6 months following treatment, in contrast to the tendency for elevation in those 9 subjects who relapsed within 6 months. CSF-SRIF showed no similar pattern. High, or even increasing, CSF-CRH concentration during antidepressant treatment may indicate lack of normalization of an underlying process in major depression despite symptomatic improvement and predicted early relapse.
Keywords
MedicineNeuroscience
ScienceElevated Concentrations of CSF Corticotropin-Releasing Factor-Like Immunoreactivity in Depressed Patients
1,487 Citations1984Charles B. Nemeroff, Erik Widerlöv +7 more
Findings are concordant with the hypothesis that CRF hypersecretion is, at least in part, responsible for the hyperactivity of the hypothalamo-pituitary-adrenal axis characteristic of major depression.
The British Journal of PsychiatryThe Dexamethasone Suppression Test for Melancholia
773 Citations1982Bernard J. Carroll
This review will focus on the most widely studied neuroendocrine disturbance: disinhibition of the hypothalamus-pituitary-adrenal cortex (HPA) system as revealed by the dexamethasone suppression test (DST).
Archives of General PsychiatryReduced Corticotropin Releasing Factor Binding Sites in the Frontal Cortex of Suicide Victims
555 Citations1988Charles B. Nemeroff
There was a marked (23%) reduction in the number of CRF binding sites in the frontal cortex of the suicide victims compared with the controls, which is consistent with the hypothesis that CRF is hypersecreted in depression.
American Journal of PsychiatryPsychiatric implications of basic and clinical studies with corticotropin-releasing factor
481 Citations1984P W Gold, George P. Chrousos +7 more
Clinically, experience in administering ovine CRF shows that CRF can be helpful in resolving differential diagnostic dilemmas in patients with various disorders of the hypothalamic-pituitary-adrenal axis and in furthering an understanding of the pathophysiology of conditions such as Cushing's disease and depression.
American Journal of PsychiatryCSF corticotropin-releasing factor-like immunoreactivity in depression and schizophrenia
336 Citations1987Csaba M. Bánki, Garth Bissette +3 more
The authors measured CRF-like immunoreactivity in CSF samples from 138 neurological control, 54 depressed, and 27 nondepressed patients to provide further support for the hypothesis that CRF hypersecretion occurs in major depression.
PubMedCorticotropin-releasing factor and behavior.
292 Citations1985G F Koob, F E Bloom
Results suggest that CRF liberated directly into the central nervous system may have a neurotropic action important for mobilizing behavioral responses to stress.
The British Journal of PsychiatryNeuropeptide Concentrations in the Cerebrospinal Fluid of Depressed Patients Treated with Electroconvulsive Therapy
255 Citations1991Charles B. Nemeroff, Garth Bissette +2 more
The increase in CSF concentrations of CRF and β-endorphin in depressed patients is seen to be state-dependent, and the decrease after ECT, while the concentration of somatostatin increased, although the latter difference did not attain statistical significance.
Archives of General PsychiatryCortisol Secretion in Endogenous Depression
255 Citations1985Uriel Halbreich
The mean plasma level of cortisol between 1 and 4 PM was found to be highly correlated with the means 24h PC value in ED patients, as has been previously reported in normal subjects and patients with various other diseases.
Biological PsychiatryElevated CSF CRF in suicide victims
204 Citations1989Mihály Arató, Csaba M. Bánki +2 more
Measurement of the concentration of immunoreactive corticotropinreleasing factor (CRF) in CSF, a new research tool in the investigation of completed suicides, found no differences inCSF cortisol and adrenocorticotrophic hormone (ACTH) in suicides and controls.
American Journal of PsychiatryCSF corticotropin-releasing hormone in depressed patients and normal control subjects
184 Citations1987Alec Roy, David Pickar +4 more
The authors suggest that these results support the hypothesis that hypercortisolism in depressed patients in part reflects a defect at or above the hypothalamus, resulting in hypersecretion of CRH.
PharmacopsychiatryThe Role of Corticotropin-Releasing Factor in the Pathogenesis of Major Depression
183 Citations1988Charles B. Nemeroff
The hypothesis that CRF is hypersecreted in patients with major depression, the concentration of CRF in cerebrospinal fluid (CSF) in drug-free depressed patients and age- and sex-matched controles was measured in two studies, and depressed patients exhibited a clear group-related increase in CSF CRF concentrations.
EndocrinologyMechanisms of Serotonin Receptor Agonist-Induced Activation of the Hypothalamic-Pituitary-Adrenal Axis in the Rat
165 Citations1990Aldo E. Calogero, György Bagdy +4 more
ACTH and corticosterone responses to 8-OH-DPAT, m-CPP, and DOI were examined in rats whose HPA axis had been suppressed by a single high dose injection of dexamethasone, suggesting that both of these 5-HT agonists may also act at the pituitary level to stimulate ACTH release in vivo.
PubMedNormalization of dexamethasone suppression test: a laboratory index of recovery from endogenous depression.
146 Citations1980Greden Jf, Albala Aa +5 more
This study compared ten unipolar or bipolar endogenous depressives who had an abnormal DST on admission and a normal DST at discharge, with four patients whose abnormal D ST on admission failed to convert at discharge and those whose DST fail to convert showed substantially less improvement.
PubMedDexamethasone suppression test: a review of contemporary confusion.
139 Citations1985Bernard J. Carroll
While its ultimate significance is not yet known, the DST, like other laboratory tests, may help to resolve uncertainty in clinical diagnosis and refine current paradigms for psychiatric nosology and diagnosis.
Archives of General PsychiatryAlterations in Cerebrospinal Fluid Concentrations of Somatostatinlike Immunoreactivity in Neuropsychiatric Disorders
112 Citations1986Garth Bissette
Findings confirm previous reports of decreased concentrations of somatostatinlike immunoreactivity in the CSF of patients with depression and dementia and extend this observation to patients with schizophrenia as well.
PsychoneuroendocrinologyClinical studies with corticotropin releasing factor: implications for the diagnosis and pathophysiology of depression, Cushing's disease, and adrenal insufficiency
111 Citations1985Philip W. Gold, George P. Chrousos
Data from experimental animals show that CRF may influence several processes known to be altered in the overall symptom complex of depression, including not only pituitary-adrenal function, but also motor activity, appetite regulation and sexual behavior.
PsychoneuroendocrinologyLow levels of somatostatin in human CSF mark depressive episodes
87 Citations1984Hans Ågren, Gudmar Lundqvist
Results indicate low levels of CSF somatostatin to be a state marker for episodes of depression characterized by sad appearance, feelings of tiredness, insomnia, and subjective inability to acknowledge any external precipitants for the depression.
Acta Psychiatrica ScandinavicaPSYCHIATRIC DISORDERS AND UNEMPLOYMENT IN EDMONTON
81 Citations1988Roger Bland, G. Stebelsky +2 more
GHQ results indicated that those experiencing periods of unemployment are also likely to have higher current symptom and stress levels than those who are employed.
Acta Psychiatrica ScandinavicaImplications of altered limbic‐hypothalamicpituitary‐adrenocortical (LHPA)‐function for neurobiology of depression
73 Citations1988Florian Holsboer
It is suggested that the neuroendocrine system constitutes a bidirectional link between the brain and humoral homeostasis in the periphery and any change of neuronal activity in the brain, regardless of whether induced by external stimuli or endogenous errors of metabolism, may result in altered composition of gene products.
Psychiatry ResearchA theory of convulsive therapy in endogenous depression: Significance of hypothalamic functions
72 Citations1980Max Fink, Jan‐Otto Ottosson
It is postulate that the antidepressant efficacy of convulsive therapy results from the increased release and more widespread cerebral distribution of hypothalamic peptides with behavioral effects, and provides a basis for clinical trials of centrally active peptides in cases of endogenous depression, and for studies of neuroendocrine functions as predictors of outcome in convulsive Therapy.
Archives of General PsychiatryCSF Somatostatin and Abnormal Response to Dexamethasone Administration in Schizophrenic and Depressed Patients
63 Citations1986Allen R. Doran
A functional relationship between hypothalamic-pituitary-adrenal axis hyperactivity and reduced CSF somatostatin level is suggested and is negatively correlated with maximum postdexamethasone cortisol level in the total and depressed patient groups.
EndocrinologySympathoadrenomedullary Inhibition by Chronic Glucocorticoid Treatment in Conscious Rats
45 Citations1988Katalin Szemeredi, György Bagdy +4 more
It is suggested that chronic cortisol treatment suppresses basal hypothalamo-pituitary-adrenocortical and basal adrenomedullary activity in conscious unrestrained rats without impairing reflexive activation of the sympathoadrenomedullARY system.
Brain ResearchDelayed effects of chronic cortisol treatment on brain and plasma concentrations of corticotropin (ACTH) and β-endorphin
10 Citations1989György Bagdy, Aldo E. Calogero +2 more
There are delayed effects of glucocorticoids on pro-opiomelanocortin peptide secretion and/or metabolism in the central nervous system, which is consistent with the impaired cognitive functions of patients with diseases, such as Cushing's syndrome and depression, that have long-lasting elevated cortisol secretion.
Somatostatin and Behavior: Preclinical and Clinical Studies
10 Citations1987Charles B. Nemeroff, Thomas J. Walsh +1 more
Since the discovery of the chemical identity of the hypothalamic hypophysiotropic hormones, considerable research has been conducted on their physiologic role in regulating the secretion of the adenohypophyseal hormones.